Cargando…

AIP mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation

Aryl hydrocarbon receptor-interacting protein (AIP) gene mutations (AIPmut) are the most frequent germline mutations found in apparently sporadic pituitary adenomas (SPA). Our aim was to evaluate the frequency of AIPmut among young Brazilian patients with SPA. We performed an observational cohort st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Araujo, Paula Bruna, Kasuki, Leandro, de Azeredo Lima, Carlos Henrique, Ogino, Liana, Camacho, Aline H S, Chimelli, Leila, Korbonits, Márta, Gadelha, Monica R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704447/ https://www.ncbi.nlm.nih.gov/pubmed/29074612 http://dx.doi.org/10.1530/EC-17-0237

Ejemplares similares

Apoplexy in sporadic pituitary adenomas: a single referral center experience and AIP mutation analysis
por: Fialho, Christhiane, et al.
Publicado: (2021)

Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
por: Dénes, Judit, et al.
Publicado: (2015)

Risk category system to identify pituitary adenoma patients with AIP mutations
por: Caimari, Francisca, et al.
Publicado: (2018)

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2015)

Growth hormone-releasing hormone-secreting pulmonary neuroendocrine tumor associated with pituitary hyperplasia and somatotropinoma
por: Lamback, Elisa B., et al.
Publicado: (2021)

Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition
por: Morgan, Rhodri M. L., et al.
Publicado: (2012)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
por: Daly, Adrian F, et al.
Publicado: (2019)

Experience with pegvisomant treatment in acromegaly in a single Brazilian tertiary reference center: efficacy, safety and predictors of response
por: Kasuki, Leandro, et al.
Publicado: (2016)

Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families
por: Igreja, Susana, et al.
Publicado: (2010)

Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas
por: Gaspar, L. M., et al.
Publicado: (2023)

ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieria Neto, Leonardo, et al.
Publicado: (2013)

Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieira Neto, Leonardo, et al.
Publicado: (2013)

AIP gene germline variants in adult Polish patients with apparently sporadic pituitary macroadenomas
por: Trofimiuk-Müldner, Małgorzata, et al.
Publicado: (2023)

The genetic background of acromegaly
por: Gadelha, Mônica R., et al.
Publicado: (2017)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family
por: Marques, Pedro, et al.
Publicado: (2018)

Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview
por: Bilbao Garay, Ismene, et al.
Publicado: (2020)

MON-300 AIP Gene Germline Mutations in Non-Selected Patients with Apparently Sporadic Pituitary Macrodenomas
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2020)

A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma
por: Salvatori, Roberto, et al.
Publicado: (2014)

Molecular evidence and clinical importance of β‐arrestins expression in patients with acromegaly
por: Coelho, Maria Caroline Alves, et al.
Publicado: (2018)

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
por: Barry, Sayka, et al.
Publicado: (2019)

SUN-322 Worsening of Carcinoid Syndrome during Lutetium Therapy in a Patient with Bronchial Carcinoid and Acromegaly
por: Baranski Lamback, Elisa, et al.
Publicado: (2019)

Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2018)

Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles
por: Coelho, Maria Caroline Alves, et al.
Publicado: (2019)

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors
por: Marques, Pedro, et al.
Publicado: (2020)

Clinical and Pathological Aspects of Silent Pituitary Adenomas
por: Drummond, Juliana, et al.
Publicado: (2018)

AIP variant causing familial prolactinoma
por: Carty, David M., et al.
Publicado: (2020)

The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study
por: Coopmans, E. C., et al.
Publicado: (2020)

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
por: Henriques, Daniel G., et al.
Publicado: (2023)

Cantú syndrome with coexisting familial pituitary adenoma
por: Marques, Pedro, et al.
Publicado: (2018)

A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
por: Vieira, Leonardo, et al.
Publicado: (2016)

The NETting of pituitary adenoma: a gland illusion
por: Ho, Ken K. Y., et al.
Publicado: (2022)

Novel AIP mutation in exon 6 causing acromegaly in a German family
por: Detomas, M., et al.
Publicado: (2023)

In vivo bioassay to test the pathogenicity of missense human AIP variants
por: Aflorei, Elena Daniela, et al.
Publicado: (2018)

THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
por: Wang, Xian, et al.
Publicado: (2023)

SAT-462 AIP Mutation-Positive Patients with Somatotropinomas End up Taller and Requiring Radiotherapy More Often Compared to AIP Mutation-Negative Patients: Data from 784 Familial and Young-Onset Cases
por: Marques, Pedro, et al.
Publicado: (2019)

Mixed gangliocytoma-pituitary adenoma containing GH and GHRH co-secreting adenoma cells
por: Teramoto, Shinichiro, et al.
Publicado: (2019)

gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
por: Wildemberg, Luiz Eduardo, et al.
Publicado: (2021)

Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas
por: Foltran, R.K., et al.
Publicado: (2018)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism
por: Imran, Syed Ali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r1g58ddqa8p0dusf8r1tbaj9v7